WinstonWınston
Imagenetix logo

Imagenetix

IAGX
23
Drug Manufacturers - Specialty & Generic · Healthcare
Price
$0.00
+0.00 (+0.00%)
Market Cap
$2,842
Winston Score
23
Winston is worried
Weak fundamentals across most pillars.

Share count rising — dilution

+159.2% over 7y

The company has issued more shares over this period, which dilutes each existing shareholder’s stake.

Diluted shares outstanding: 10.9M (2008) → 28.3M (2015)

Imagenetix, Inc. is a small healthcare company that develops and sells nutritional supplements and over-the-counter health products. Its core offerings include joint health, pain relief, and wellness supplements sold mainly to consumers through retail channels and direct distribution. The company operates in the specialty health products space, competing alongside many other small supplement makers.

Imagenetix makes money by selling its finished products to distributors, retailers, and directly to customers. It operates primarily in the United States and is a very small company, with a market cap that rounds to essentially zero, meaning it has limited financial resources compared to larger peers. Its gross margin of around 42% is reasonable for a supplement business, but its razor-thin operating margin of under 2% and very low return on invested capital suggest the company struggles to turn sales into meaningful profit — and sustaining growth while managing costs remains the central challenge it faces.

Winston Score History

Growth Profile

When traditional metrics don't capture the full picture, these are the signals growth stock investors use instead.

Revenue Growth

YoY Growth Rate

Revenue data limited

EPS Growth

YoY Growth Rate

EPS data limited

R&D Spend

$0/ year

0.0% of revenue

Below sector average (18%)

Research and development spending

Insider Activity

63.7%ownership

Flat

Insiders holding steady — not selling despite ability to

Cash Runway

~4 years

$92,389 cash & investments

$92,389 cash & investments at current burn rate

The Winston Score above measures business quality today. Growth stocks often score lower because they invest in the future rather than maximising current profits. These metrics show what matters most for evaluating that future.

Score breakdown

Every number that matters to educated investors.

Each metric is explained in plain language so you know exactly what you're looking at. Start your free trial now.

Quality

Gross Margin
75.6%
Premium pricing power — 75.6% gross margin
Operating Margin
-13.5%
Losing money on operations — -13.5%
ROCE
-0.8%
Weak — -0.8% return on capital

Negative ROIC means the business is losing money on every dollar invested in it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Growth

Sales YoY
-50.0%
Shrinking sales (-50.0% YoY)
EPS YoY
N/A
Data not available
EPS Consistency
2/8 quarters
Earnings rarely grow — volatile business

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Cash Flow

Cash Conversion
N/A
Data not available
FCF Margin
-36.1%
Burning cash (-36.1%)

Free cash flow is negative. They are burning cash, not generating it.

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Stability

Debt / Equity
N/A
Data not available
Interest Cover
N/A
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Valuation

P/E Ratio (TTM)
N/M
Negative earnings — P/E not meaningful
P/E vs Forward
N/A
not available
Data not available

Full breakdown available with your free trial

See every metric, trend, and what it means for this stock.

Try free

Dividends

Not applicable for this business.
🔒 See full fundamentals and if they are improving or declining — click here for your free trial now.
Start free trial